news (earnings followup)Thanks to all for their input regarding future earnings prospects. Certainly an interesting company. I have experience following several other biotechs, though specifically in the oncology area. Most I find are long shots that don't pan out, but when one does, the returns are dazzling.
Clearly, this company is not a one trick pony and some value drivers are real.
One other question to those who have followed this company closely, are there specific, anticpipated dates in the near term for any press releases? For instance: IND results, clinical trial commencement, clinical trial results etc...